SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 19, 2026

ARTV

Artiva Biotherapeutics, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed6mo ago
Insider cluster: 2 insiders, $308K total
Actionable Insight ▼ Bearish

The CEO and CMO selling at $9.01-28% below the May 7 offering price of $11.52, suggests insiders see limited near-term upside post-dilution and post-catalyst. Monitor for additional insider selling in the next 30 days; if C-suite continues to sell, it would reinforce a bearish read. The $300M cash raise funds operations into Q2 2027, but the stock's post-offering slide indicates the market is pricing in heavy dilution.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$7.84
T+0 close · May 19, 2026 · via day close
Latest settled
+25.26%
T+20 · $9.82
Vs SPY
+24.51%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · May 20 $7.84entry
  2. T+1 · 6mo ago +1.91%α +1.72% · $7.99
  3. T+5 · 6mo ago −2.93%α −4.74% · $7.61
  4. T+20 · 5mo ago +25.26%α +24.51% · $9.82
  5. T+60 · due 3mo ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Fred Aslan and CMO Subhashis Banerjee sold a combined $308K in open-market sales on May 19, 2026, just 11 days after a $300M dilutive offering priced at $11.52/share and 12 days after positive Phase 2a RA data. The sales are small relative to the $228M market cap (0.14%), but the timing, immediately after a large secondary and at a price ($9.01) well below the offering price, raises concern that insiders are reducing exposure post-dilution and post-catalyst. The cluster is amplified by the cross-filing context of a recent capital raise and earnings release.

Key Financial Metrics

Direction
selling
Total Value
$308.0K
Insiders
2

Key Facts

  • CEO Fred Aslan sold 27,116 shares for $244K on May 19, 2026 at $9.01
  • CMO Subhashis Banerjee sold 7,037 shares for $63K on May 19, 2026 at $9.01
  • President Diego Miralles received 310,000 shares via non-cash grants on May 18, 2026 ($0 value)
  • Total open-market sales: $308K, representing 0.14% of $228M market cap
  • Sales occurred 11 days after a $300M dilutive offering at $11.52/share and 12 days after positive Phase 2a RA data
  • Stock price has declined from $12.52 (May 7) to $9.01 (May 19), a 28% drop

Financial Impact

Insider sales of $308K (0.14% of market cap) are modest in absolute terms but notable for timing and price level

insider_sellingdilutionstock_price

Risk Factors

  • Further insider selling could signal deteriorating confidence in near-term catalysts
  • The $300M offering at $11.52 created massive dilution (26M shares, ~50% of pre-offer float), pressuring the stock
  • Pre-revenue biotech with cash burn of ~$23.5M/quarter; positive Phase 2a data may not translate to Phase 3 success

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARTV-1779241868981

Track record

33 reports on ARTV

Performance horizon

11 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
  2. Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
  3. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
  4. Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
  5. Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
  6. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  7. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  10. Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
Showing 10 of 33

US Market Status

Market Closed · Opens in 8h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026